Literature DB >> 8755943

A common BRCA1 mutation in Norwegian breast and ovarian cancer families?

T I Andersen, A L Børresen, P Møller.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8755943      PMCID： PMC1914717     

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN： 0002-9297            Impact factor:   11.025


× No keyword cloud information.
  3 in total

1.  A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1.

Authors:  Y Miki; J Swensen; D Shattuck-Eidens; P A Futreal; K Harshman; S Tavtigian; Q Liu; C Cochran; L M Bennett; W Ding
Journal:  Science       Date:  1994-10-07       Impact factor: 47.728

2.  The carrier frequency of the BRCA1 185delAG mutation is approximately 1 percent in Ashkenazi Jewish individuals.

Authors:  J P Struewing; D Abeliovich; T Peretz; N Avishai; M M Kaback; F S Collins; L C Brody
Journal:  Nat Genet       Date:  1995-10       Impact factor: 38.330

3.  Common origins of BRCA1 mutations in Canadian breast and ovarian cancer families.

Authors:  J Simard; P Tonin; F Durocher; K Morgan; J Rommens; S Gingras; C Samson; J F Leblanc; C Bélanger; F Dion
Journal:  Nat Genet       Date:  1994-12       Impact factor: 38.330
  3 in total
  13 in total

1.  Frequencies of single-nucleotide polymorphisms and mutations in the BRCA1 gene in patients with hereditary breast or ovarian cancer.

Authors:  A V Karpukhin; N I Pospekhova; L N Lubchenko; A N Loginova; E V Khomich; A V Budilov; A S Sergeev; V M Zakhar'ev; R F Gar'kavtseva; E K Ginter
Journal:  Dokl Biol Sci       Date:  2002 Mar-Apr

2.  Population genetics of BRCA1 and BRCA2.

Authors:  C I Szabo; M C King
Journal:  Am J Hum Genet       Date:  1997-05       Impact factor: 11.025

3.  Frequency of 5382insC mutation of BRCA1 gene among breast cancer patients: an experience from Eastern India.

Authors:  Abhijit Chakraborty; Ashis Mukhopadhyay; Deboshree Bhattacharyya; Chinmoy Kr Bose; Keya Choudhuri; Soma Mukhopadhyay; Jayasri Basak
Journal:  Fam Cancer       Date:  2013-09       Impact factor: 2.375

4.  Penetrances of BRCA1 1675delA and 1135insA with respect to breast cancer and ovarian cancer.

Authors:  A Dørum; K Heimdal; E Hovig; M Inganäs; P Møller
Journal:  Am J Hum Genet       Date:  1999-09       Impact factor: 11.025

5.  A high proportion of novel mutations in BRCA1 with strong founder effects among Dutch and Belgian hereditary breast and ovarian cancer families.

Authors:  T Peelen; M van Vliet; A Petrij-Bosch; R Mieremet; C Szabo; A M van den Ouweland; F Hogervorst; R Brohet; M J Ligtenberg; E Teugels; R van der Luijt; A H van der Hout; J J Gille; G Pals; I Jedema; R Olmer; I van Leeuwen; B Newman; M Plandsoen; M van der Est; G Brink; S Hageman; P J Arts; M M Bakker; P Devilee
Journal:  Am J Hum Genet       Date:  1997-05       Impact factor: 11.025

6.  Founder mutations in the BRCA1 gene in Polish families with breast-ovarian cancer.

Authors:  B Górski; T Byrski; T Huzarski; A Jakubowska; J Menkiszak; J Gronwald; A Pluzańska; M Bebenek; L Fischer-Maliszewska; E Grzybowska; S A Narod; J Lubiński
Journal:  Am J Hum Genet       Date:  2000-04-28       Impact factor: 11.025

Review 7.  The genetics of inherited breast cancer.

Authors:  S A Gayther; P D Pharoah; B A Ponder
Journal:  J Mammary Gland Biol Neoplasia       Date:  1998-10       Impact factor: 2.673

8.  Using gene carrier probability to select high risk families for identifying germline mutations in breast cancer susceptibility genes.

Authors:  J Chang-Claude; J Dong; S Schmidt; M Shayeghi; D Komitowski; H Becher; M R Stratton; B Royer-Pokora
Journal:  J Med Genet       Date:  1998-02       Impact factor: 6.318

Review 9.  Pathology of hereditary breast cancer.

Authors:  Petra van der Groep; Elsken van der Wall; Paul J van Diest
Journal:  Cell Oncol (Dordr)       Date:  2011-02-19       Impact factor: 6.730

10.  TP53 mutations in ovarian carcinomas from sporadic cases and carriers of two distinct BRCA1 founder mutations; relation to age at diagnosis and survival.

Authors:  Pedro Kringen; Yun Wang; Vanessa Dumeaux; Jahn M Nesland; Gunnar Kristensen; Anne-Lise Borresen-Dale; Anne Dorum
Journal:  BMC Cancer       Date:  2005-10-17       Impact factor: 4.430
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.